HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ruscetti, F. W. Articles by Chervenick, P. A. Search for Related Content PubMed Articles by Ruscetti, F. W. Articles by Chervenick, P. A.

Regulation of the Release of Colony-Stimulating Activity from Mitogen-Stimulated Lymphocytes¹

From the Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261

Abstract

Lymphocytes stimulated by Concanavalin A (Con A) as well as other mitogens release colony stimulating activity (CSA) which stimulated granulocyte and mononuclear cell formation from hematopoietic progenitor cells in vitro. Removal of Con A from lymphocyte cultures by the competitive inhibitor, methyl mannoside, resulted in the cessation of CSA release regardless of the time the inhibitor was added to the cultures. However, removal of Con A after 6 hr of incubation had no effect on cellular DNA synthesis and lymphocyte transformation. In addition, vinblastine and cytosine arabinoside completely inhibited DNA synthesis but had no effect on CSA release. CSA release is dependent on an active energy process since it was completely and reversibly inhibited by the inhibitors of protein synthesis puromycin and cycloheximide. These results suggest that CSA release from stimulated lymphocytes requires continuous binding of mitogen and active protein synthesis but is not dependent on DNA synthesis and cell proliferation.

Footnotes

¹ This work was presented in part at the annual meeting of the American Society of Hematology, December, 1974. This study was aided by grants from the National Institutes of Health (1 RO1 CA14278 01A1) and the American Cancer Society (ET-10C).

² Leukemia Society of America Scholar.

This article has been cited by other articles:

				S. C. McKarns, R. H. Schwartz, and N. E. Kaminski Smad3 Is Essential for TGF-{beta}1 to Suppress IL-2 Production and TCR-Induced Proliferation, but Not IL-2-Induced Proliferation J. Immunol., April 1, 2004; 172(7): 4275 - 4284. [Abstract] [Full Text] [PDF]